ID

21083

Descripción

A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00448591

Link

https://clinicaltrials.gov/show/NCT00448591

Palabras clave

Versiones (1)
  1. 9/4/17 9/4/17 -
Subido en

9 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer DRKS00003642 NCT00448591

Inglés

Eligibility Breast Cancer NCT00448591

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients, >=18 years of age;
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
her-2 negative adenocarcinoma of the breast, with locally recurrent or metastatic disease; (her-2 positive patients only if previously treated with herceptin in the adjuvant setting;
Descripción

adenocarcinoma of the breast, her-2 negative, locally recurrent or metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C3853888
UMLS CUI [1,3]
C0338204
UMLS CUI [2]
C0861355
UMLS CUI [3]
C1697918
candidates for chemotherapy.
Descripción

chemotherapy candidate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332149
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous chemotherapy for metastatic or locally recurrent breast cancer;
Descripción

previous chemotherapy for metastatic or locally recurrent breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0205156
concomitant hormonal therapy for metastatic or locally recurrent disease;
Descripción

concomitant hormonal therapy for metastatic or locally recurrent breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0521115
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C0279025
UMLS CUI [2,3]
C0521115
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive disease;
Descripción

concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C3853888
UMLS CUI [1,3]
C0338204
UMLS CUI [1,4]
C0521115
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C3853888
UMLS CUI [2,3]
C0338204
UMLS CUI [2,4]
C0521115
previous radiotherapy for treatment of metastatic disease;
Descripción

previous radiotherapy of metastatic breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0205156
evidence of cns metastases.
Descripción

breast cancer with cns metastases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C0686377
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00448591

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
patients, >=18 years of age;
boolean
C0001779 (UMLS CUI [1])
adenocarcinoma of the breast, her-2 negative, locally recurrent or metastatic
Item
her-2 negative adenocarcinoma of the breast, with locally recurrent or metastatic disease; (her-2 positive patients only if previously treated with herceptin in the adjuvant setting;
boolean
C0858252 (UMLS CUI [1,1])
C3853888 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])
C0861355 (UMLS CUI [2])
C1697918 (UMLS CUI [3])
chemotherapy candidate
Item
candidates for chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy for metastatic or locally recurrent breast cancer
Item
previous chemotherapy for metastatic or locally recurrent breast cancer;
boolean
C0278493 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C1697918 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
concomitant hormonal therapy for metastatic or locally recurrent breast cancer
Item
concomitant hormonal therapy for metastatic or locally recurrent disease;
boolean
C0278493 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0521115 (UMLS CUI [1,3])
C1697918 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0521115 (UMLS CUI [2,3])
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive breast cancer
Item
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive disease;
boolean
C0278493 (UMLS CUI [1,1])
C3853888 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])
C0521115 (UMLS CUI [1,4])
C1697918 (UMLS CUI [2,1])
C3853888 (UMLS CUI [2,2])
C0338204 (UMLS CUI [2,3])
C0521115 (UMLS CUI [2,4])
previous radiotherapy of metastatic breast cancer
Item
previous radiotherapy for treatment of metastatic disease;
boolean
C1697918 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
breast cancer with cns metastases
Item
evidence of cns metastases.
boolean
C1697918 (UMLS CUI [1,1])
C0686377 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial